Business · 22/03/2010
FDA Requests Public Comment on Proposed Collection of Information for Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to the guidance on drug labeling for cardiovascular outcome claims for drugs treating hypertension, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Health and Human ServicesOpen original release →